( 3 ) readily reproducible and often marked therapeutic synergism between a variety of 2-drug combinations of alkylating agents against a wide variety of histologic types of murine tumors , and ( 4 ) observed resistance and cross-resistance of a variety of murine tumors , selected for resistance to specific alkylating agents , compatible with recognized chemical and functional differences between these drugs .
C0027652
of histologic types
C0027651
tumors